Publications

03-29 05:28
 
Chronic granulomatous disease. Report on a national registry of 368 patients
03-29 05:28
 
The outcomes of a 12-week Internet intervention aimed at improving fitness and health-related quality of life in overweight adolescents: the Young & Active controlled trial
03-29 05:28
 
Overweight adolescents' views on physical activity - experiences of participants in an internet-based intervention: a qualitative study
03-29 05:28
 
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study
03-29 05:28
 
Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
03-29 05:27
 
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study
03-29 05:27
 
Continuous care intervention with carbohydrate restriction improves physical function of the knees among patients with type 2 diabetes: a non-randomized study
03-29 05:27
 
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor
03-29 05:27
 
Adherence to a low-fat vs. low-carbohydrate diet differs by insulin resistance status
03-29 05:27
 
Tailoring dietary approaches for weight loss
03-29 05:27
 
FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial
03-29 05:27
 
Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial
03-29 05:27
 
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
03-29 05:27
 
Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up
03-29 05:27
 
A low-carbohydrate, ketogenic diet to treat type 2 diabetes
03-29 05:27
 
Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction
03-29 05:27
 
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
03-29 05:27
 
Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006
03-29 05:27
 
Prevalence of obesity among adults: United States, 2011-2012
03-29 05:27
 
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network
03-29 05:27
 
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial
03-29 05:27
 
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial
03-29 05:27
 
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes
03-29 05:27
 
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial
03-29 05:27
 
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms

Clinical Research News

Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma

Предстоящие клинические испытания

Clinical Research Jobs

All jobs

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться